Bonesupport Holding AB (publ) (STO:BONEX)

Market Cap	20.94B +24.2%
Revenue (ttm)	1.40B +25.2%
Net Income	271.77M +78.9%
EPS	4.08 +79.0%
Shares Out	65.49M
PE Ratio	78.40
Forward PE	44.16
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,489,567
Open	275.60
Previous Close	257.20
Day's Range	273.20 - 322.20
52-Week Range	165.00 - 321.60
Beta	0.31
Analysts	Strong Buy
Price Target	357.42 (+11.76%)
Earnings Date	Oct 22, 2026

About Bonesupport Holding AB

Bonesupport Holding AB (publ), an orthobiologics company, develops and commercializes injectable bio-ceramic bone graft substitutes in the United States, Europe, and internationally. The company offers CERAMENT Bone Void Filler, an injectable ceramic bone graft substitute that remodels to host bone; CERAMENT G, an injectable ceramic bone graft substitute that remodels to host bone and elutes Gentamicin during the critical first 30 days of bone healing, as well as treats and prevents bone infection; and CERAMENT V, an injectable ceramic bone gra...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1999
• Employees: 171
• Stock Exchange: Nasdaq Stockholm
• Ticker Symbol: BONEX

Financial Performance

In 2025, Bonesupport Holding AB's revenue was 1.17 billion, an increase of 30.70% compared to the previous year's 898.73 million. Earnings were 142.15 million, an increase of 6.28%.

Analyst Summary

According to 5 analysts, the average rating for BONEX stock is "Strong Buy." The 12-month stock price target is kr 357.42, which is an increase of 11.76% from the latest price.

Price Target

kr 357.42

(11.76% upside)

Analyst Consensus: Strong Buy

Data Sources: S&P Global Market Intelligence and QUODD

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by QUODD.

Last checked:

Oct 22, 2026

Data Sources Report a data error